ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

Twice-Daily vs. Once-Daily Dolutegravir in Patients With Human Immunodeficiency Virus-Tuberculosis Coinfection Receiving Rifampicin-Based Tuberculosis Therapy.

Sanghyuk S Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.